12-123712552-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000540368.6(ATP6V0A2):​n.18C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.371 in 1,562,770 control chromosomes in the GnomAD database, including 111,534 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 10274 hom., cov: 32)
Exomes 𝑓: 0.37 ( 101260 hom. )

Consequence

ATP6V0A2
ENST00000540368.6 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.43

Publications

13 publications found
Variant links:
Genes affected
ATP6V0A2 (HGNC:18481): (ATPase H+ transporting V0 subunit a2) The protein encoded by this gene is a subunit of the vacuolar ATPase (v-ATPase), an heteromultimeric enzyme that is present in intracellular vesicles and in the plasma membrane of specialized cells, and which is essential for the acidification of diverse cellular components. V-ATPase is comprised of a membrane peripheral V(1) domain for ATP hydrolysis, and an integral membrane V(0) domain for proton translocation. The subunit encoded by this gene is a component of the V(0) domain. Mutations in this gene are a cause of both cutis laxa type II and wrinkly skin syndrome. [provided by RefSeq, Jul 2009]
ATP6V0A2 Gene-Disease associations (from GenCC):
  • wrinkly skin syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp
  • autosomal recessive cutis laxa type 2, classic type
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Orphanet
  • autosomal recessive cutis laxa type 2A
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 12-123712552-C-T is Benign according to our data. Variant chr12-123712552-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95515.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.402 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP6V0A2NM_012463.4 linkc.-14C>T 5_prime_UTR_variant Exon 1 of 20 ENST00000330342.8 NP_036595.2 Q9Y487
ATP6V0A2XM_024448910.2 linkc.-14C>T 5_prime_UTR_variant Exon 1 of 19 XP_024304678.1
LOC105370042XR_945477.4 linkn.*214G>A downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP6V0A2ENST00000330342.8 linkc.-14C>T 5_prime_UTR_variant Exon 1 of 20 1 NM_012463.4 ENSP00000332247.2 Q9Y487

Frequencies

GnomAD3 genomes
AF:
0.359
AC:
54506
AN:
151840
Hom.:
10267
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.407
Gnomad AMI
AF:
0.513
Gnomad AMR
AF:
0.270
Gnomad ASJ
AF:
0.327
Gnomad EAS
AF:
0.0569
Gnomad SAS
AF:
0.314
Gnomad FIN
AF:
0.297
Gnomad MID
AF:
0.385
Gnomad NFE
AF:
0.385
Gnomad OTH
AF:
0.354
GnomAD2 exomes
AF:
0.322
AC:
54591
AN:
169792
AF XY:
0.330
show subpopulations
Gnomad AFR exome
AF:
0.439
Gnomad AMR exome
AF:
0.202
Gnomad ASJ exome
AF:
0.328
Gnomad EAS exome
AF:
0.0587
Gnomad FIN exome
AF:
0.310
Gnomad NFE exome
AF:
0.396
Gnomad OTH exome
AF:
0.352
GnomAD4 exome
AF:
0.372
AC:
525012
AN:
1410818
Hom.:
101260
Cov.:
31
AF XY:
0.371
AC XY:
259445
AN XY:
699290
show subpopulations
African (AFR)
AF:
0.423
AC:
13482
AN:
31886
American (AMR)
AF:
0.210
AC:
8141
AN:
38848
Ashkenazi Jewish (ASJ)
AF:
0.323
AC:
8137
AN:
25176
East Asian (EAS)
AF:
0.0468
AC:
1719
AN:
36702
South Asian (SAS)
AF:
0.337
AC:
27498
AN:
81662
European-Finnish (FIN)
AF:
0.304
AC:
12897
AN:
42396
Middle Eastern (MID)
AF:
0.372
AC:
1964
AN:
5280
European-Non Finnish (NFE)
AF:
0.395
AC:
430310
AN:
1090398
Other (OTH)
AF:
0.357
AC:
20864
AN:
58470
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
17068
34136
51205
68273
85341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13330
26660
39990
53320
66650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.359
AC:
54545
AN:
151952
Hom.:
10274
Cov.:
32
AF XY:
0.354
AC XY:
26279
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.407
AC:
16902
AN:
41484
American (AMR)
AF:
0.270
AC:
4123
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.327
AC:
1135
AN:
3468
East Asian (EAS)
AF:
0.0569
AC:
293
AN:
5150
South Asian (SAS)
AF:
0.313
AC:
1511
AN:
4828
European-Finnish (FIN)
AF:
0.297
AC:
3133
AN:
10544
Middle Eastern (MID)
AF:
0.380
AC:
111
AN:
292
European-Non Finnish (NFE)
AF:
0.385
AC:
26132
AN:
67882
Other (OTH)
AF:
0.349
AC:
738
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1783
3565
5348
7130
8913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.364
Hom.:
1832
Bravo
AF:
0.358

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 25, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Joubert syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cutis Laxa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Meckel-Gruber syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cutis laxa with osteodystrophy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
16
DANN
Benign
0.95
PhyloP100
1.4
PromoterAI
-0.075
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1139320; hg19: chr12-124197099; API